aXichem
1,3
SEK
-11,26 %
AXIC A
First North Stockholm
Chemicals
Basic Materials
Vær den første som følger denne virksomhed
-11,26%
-11,56%
-8,13%
+4,84%
-66,59%
-82,28%
-94,15%
-98,45%
-92,3%
www.axichem.com
aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company mainly works with Phenylcapsaicin, a natural analog synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, as well as among individual pharmaceutical work areas. Operations are run on a global level, with the head office in Malmö.
Omsætning
1,81 mio.
EBIT %
-956,91 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
AXIC A
Daglig lav / høj pris
1,3 / 1,445
SEK
Markedsværdi
76,85 mio. SEK
Aktieomsætning
165,85 t SEK
Volumen
122 t
Finanskalender
Årsrapport
27.02.2025
Delårsrapport
22.05.2025
Generalforsamling
18.06.2025
Delårsrapport
28.08.2025
Delårsrapport
28.11.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
LMK Bolagen | 15,5 % | 15,5 % |
Manakin Ltd | 7,2 % | 7,2 % |
Avanza Pension | 5,3 % | 5,3 % |
Nordnet Pensionsförsäkring AB | 4,5 % | 4,5 % |
Aksjesel. Arbejdenes Landsbank | 2,9 % | 2,9 % |
Myacom Investment AB | 2,8 % | 2,8 % |
Fenja Capital II | 2,3 % | 2,3 % |
Sydbank | 2,2 % | 2,2 % |
Pierre Sahlstrand | 2,1 % | 2,1 % |
Christian Månsson | 1,9 % | 1,9 % |
ViserAlle indholdstyper
aXichem AB: aXichem secures production capacity for phenylcapsaicin, corresponding to volumes of up to 100 tons of aXiphen-feed, for the upcoming six to nine months
aXichem AB: aXichem exhibits at Vitafoods Europe 2021 in Geneva, and launches a new website presenting the unique product aXivite
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools